. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Drug Approval/legislation & jurisprudenceDrug InteractionsDrug and Narcotic Control/legislation & jurisprudenceDrug and Narcotic Control/trendsHumansMigraine Disorders/drug therapyNonprescription Drugs/adverse effectsNonprescription Drugs/classificationNonprescription Drugs/therapeutic useOxazolidinones/adverse effectsOxazolidinones/classificationOxazolidinones/therapeutic usePharmacies/legislation & jurisprudencePharmacies/trendsSerotonin Receptor Agonists/adverse effectsSerotonin Receptor Agonists/classificationSerotonin Receptor Agonists/therapeutic useSumatriptan/adverse effectsSumatriptan/classificationSumatriptan/therapeutic useTryptaminesUnited Kingdom
Substances: See more » Nonprescription DrugsOxazolidinonesSerotonin Receptor AgonistsTryptamineszolmitriptanSumatriptan
Year: 2005 PMID: 16168921 DOI: 10.1016/S1474-4422(05)70174-5
Source DB: PubMed Journal: Lancet Neurol ISSN: 1474-4422 Impact factor: 44.182